1. Home
  2. ENTA vs SWBI Comparison

ENTA vs SWBI Comparison

Compare ENTA & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.04

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$11.67

Market Cap

491.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
SWBI
Founded
1995
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
491.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
SWBI
Price
$14.04
$11.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$20.40
$11.00
AVG Volume (30 Days)
220.0K
506.8K
Earning Date
02-09-2026
03-05-2026
Dividend Yield
N/A
4.41%
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
$66,980,000.00
$466,396,000.00
Revenue This Year
$0.99
$2.62
Revenue Next Year
$0.19
$3.23
P/E Ratio
N/A
$56.38
Revenue Growth
0.58
N/A
52 Week Low
$4.09
$7.73
52 Week High
$17.15
$12.05

Technical Indicators

Market Signals
Indicator
ENTA
SWBI
Relative Strength Index (RSI) 55.34 65.59
Support Level $13.18 $11.33
Resistance Level $15.55 $11.94
Average True Range (ATR) 0.66 0.39
MACD 0.17 0.03
Stochastic Oscillator 50.00 73.94

Price Performance

Historical Comparison
ENTA
SWBI

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: